Clinical Trial Update: Study Comparing Standard Dose and Reduced Dose Tacrolimus + Sirolimus + Corticosteroids in Renal Allograft Recipients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial comparing standard-dose versus reduced-dose tacrolimus in combination with sirolimus and corticosteroids for kidney transplant recipien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Corticosteroids (corticosteroids)
• Prograf (Tacrolimus) (Tacrolimus)
• Rapamune (sirolimus) (sirolimus)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Kidney Transplantation | Phase 2 | Status: COMPLETED